OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phagocyte-membrane-coated and laser-responsive nanoparticles control primary and metastatic cancer by inducing anti-tumor immunity
Chuan Hu, Ting Lei, Yazhen Wang, et al.
Biomaterials (2020) Vol. 255, pp. 120159-120159
Closed Access | Times Cited: 134

Showing 1-25 of 134 citing articles:

Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
Zhilin Li, Xiaoqin Lai, Shiqin Fu, et al.
Advanced Science (2022) Vol. 9, Iss. 22
Open Access | Times Cited: 378

Macrophage Cell Membrane‐Cloaked Nanoplatforms for Biomedical Applications
Joana Lopes, Daniela Lopes, Miguel Pereira‐Silva, et al.
Small Methods (2022) Vol. 6, Iss. 8
Open Access | Times Cited: 135

Cell membrane coated-nanoparticles for cancer immunotherapy
Yingping Zeng, Sufen Li, Shufen Zhang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 8, pp. 3233-3254
Open Access | Times Cited: 133

Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
Yanyan Xu, Jingyuan Xiong, Xiyang Sun, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 12, pp. 4327-4347
Open Access | Times Cited: 124

White Blood Cell Membrane‐Coated Nanoparticles: Recent Development and Medical Applications
Dan Wang, Shuyan Wang, Zhidong Zhou, et al.
Advanced Healthcare Materials (2021) Vol. 11, Iss. 7
Closed Access | Times Cited: 117

Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment
Yuesong Wu, Shengli Wan, Shuo Yang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 111

Macrophage membrane coated nanoparticles: a biomimetic approach for enhanced and targeted delivery
Nafeesa Khatoon, Zefei Zhang, Chunhui Zhou, et al.
Biomaterials Science (2022) Vol. 10, Iss. 5, pp. 1193-1208
Closed Access | Times Cited: 94

Nanocarriers surface engineered with cell membranes for cancer targeted chemotherapy
Wen Lei, Chen Yang, Yi Wu, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 81

Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics
Pengzhi Shi, Zhangrong Cheng, Kangcheng Zhao, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 73

The impact of protein corona on the biological behavior of targeting nanomedicines
Masoud Farshbaf, Hadi Valizadeh, Yunes Panahi, et al.
International Journal of Pharmaceutics (2022) Vol. 614, pp. 121458-121458
Closed Access | Times Cited: 72

A detailed insight of the tumor targeting using nanocarrier drug delivery system
Sibgha Batool, Saba Sohail, Fakhar ud Din, et al.
Drug Delivery (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 58

Paraptosis Inducer to Effectively Trigger Immunogenic Cell Death for Metastatic Tumor Immunotherapy with IDO Inhibition
Rongrong Zheng, Linping Zhao, Chu‐Yu Huang, et al.
ACS Nano (2023) Vol. 17, Iss. 11, pp. 9972-9986
Closed Access | Times Cited: 46

Cancer Nanovaccines: Nanomaterials and Clinical Perspectives
Nimeet Desai, Vivek P. Chavda, Thakur Raghu Raj Singh, et al.
Small (2024) Vol. 20, Iss. 35
Open Access | Times Cited: 23

The progress and perspective of nanoparticle-enabled tumor metastasis treatment
Wei Zhang, Fei Wang, Chuan Hu, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 10, Iss. 11, pp. 2037-2053
Open Access | Times Cited: 136

The progress and perspective of strategies to improve tumor penetration of nanomedicines
Jiang Hu, Xinwei Yuan, Fei Wang, et al.
Chinese Chemical Letters (2020) Vol. 32, Iss. 4, pp. 1341-1347
Closed Access | Times Cited: 130

Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles
Aixue Li, Yunan Zhao, Yixiu Li, et al.
Drug Delivery (2021) Vol. 28, Iss. 1, pp. 1237-1255
Open Access | Times Cited: 93

Cancer immunogenic cell death via photo-pyroptosis with light-sensitive Indoleamine 2,3-dioxygenase inhibitor conjugate
Lu Yang, Feng Xu, Yang Wang, et al.
Biomaterials (2021) Vol. 278, pp. 121167-121167
Closed Access | Times Cited: 92

Self‐Propelled Micro/Nanomotors for Tumor Targeting Delivery and Therapy
Ruyi Lin, Wenqi Yu, Xianchun Chen, et al.
Advanced Healthcare Materials (2020) Vol. 10, Iss. 1
Closed Access | Times Cited: 85

Nanovaccine‐Based Strategies to Overcome Challenges in the Whole Vaccination Cascade for Tumor Immunotherapy
Lin Qin, Huilin Zhang, Yang Zhou, et al.
Small (2021) Vol. 17, Iss. 28
Closed Access | Times Cited: 85

Shape Transformable Strategies for Drug Delivery
Wenfeng Jia, Yushan Wang, Rui Liu, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 18
Closed Access | Times Cited: 77

Hybrid Membrane-Coated Biomimetic Nanoparticles (HM@BNPs): A Multifunctional Nanomaterial for Biomedical Applications
Yunan Zhao, Aixue Li, Liangdi Jiang, et al.
Biomacromolecules (2021) Vol. 22, Iss. 8, pp. 3149-3167
Closed Access | Times Cited: 77

IL-12 nanochaperone-engineered CAR T cell for robust tumor-immunotherapy
Yingmei Luo, Ze Chen, Mingjian Sun, et al.
Biomaterials (2021) Vol. 281, pp. 121341-121341
Closed Access | Times Cited: 73

Page 1 - Next Page

Scroll to top